Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker HQY
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Sunil Rajasekar EVP Chief Prod & Strat Officer | HQY HealthEquity, Inc. | Buy | 108 | $90.33 | $9,756 Buy | Form 4 ↗ |
| Aug 25, 2026 | Adrian T. Dillon Director | HQY HealthEquity, Inc. | Sale | 1,332 | $105.26 | $140.2K Sale | Form 4 ↗ |
| Aug 25, 2026 | Adrian T. Dillon Director | HQY HealthEquity, Inc. | Sale | 6,300 | $104.47 | $658.2K Sale | Form 4 ↗ |
| Aug 24, 2026 | Sunil Rajasekar EVP Chief Prod & Strat Officer | HQY HealthEquity, Inc. | Sale | 108 | $105.60 | $11.4K Sale | Form 4 ↗ |
| Jul 10, 2026 | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | HQY HealthEquity, Inc. | Sale | 2,354 | $95.00 | $223.6K Sale | Form 4 ↗ |
| Jul 8, 2026 | Sunil Rajasekar EVP Chief Prod & Strat Officer | HQY HealthEquity, Inc. | Buy | 23 | $95.06 | $2,186 Buy | Form 4 ↗ |
| Jul 2, 2026 | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | HQY HealthEquity, Inc. | Sale | 2,470 | $95.00 | $234.7K Sale | Form 4 ↗ |
| May 29, 2026 | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | HQY HealthEquity, Inc. | Sale | 3,142 | $95.00 | $298.5K Sale | Form 4 ↗ |
| May 28, 2026 | Gayle Furgurson Wellborn Director | HQY HealthEquity, Inc. | Sale | 2,439 | $90.00 | $219.5K Sale | Form 4 ↗ |
| May 28, 2026 | Delano Ladd EVP, General Counsel | HQY HealthEquity, Inc. | Sale | 7,500 | $90.00 | $675.0K Sale | Form 4 ↗ |
| Apr 22, 2026 | Sunil Rajasekar EVP Chief Prod & Strat Officer | HQY HealthEquity, Inc. | Sale | 23 | $82.81 | $1,905 Sale | Form 4 ↗ |
| Dec 19, 2025 | Delano Ladd EVP, General Counsel | HQY HealthEquity, Inc. | Sale | 1,500 | $94.72 | $142.1K Sale | Form 4 ↗ |
| Dec 18, 2025 | Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER | HQY HealthEquity, Inc. | Sale | 10,959 | $95.45 | $1.0M Sale | Form 4 ↗ |
| Dec 12, 2025 | Gayle Furgurson Wellborn Director | HQY HealthEquity, Inc. | Sale | 4,339 | $98.03 | $425.4K Sale | Form 4 ↗ |
| Nov 20, 2025 | Delano Ladd EVP, General Counsel | HQY HealthEquity, Inc. | Sale | 1,500 | $104.56 | $156.8K Sale | Form 4 ↗ |
| Oct 20, 2025 | Delano Ladd EVP, General Counsel | HQY HealthEquity, Inc. | Sale | 1,500 | $92.07 | $138.1K Sale | Form 4 ↗ |
| Oct 7, 2025 | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | HQY HealthEquity, Inc. | Sale | 1,781 | $88.21 | $157.1K Sale | Form 4 ↗ |
| Sep 19, 2025 | Delano Ladd EVP, General Counsel | HQY HealthEquity, Inc. | Sale | 29 | $95.70 | $2,775 Sale | Form 4 ↗ |
| Sep 19, 2025 | Delano Ladd EVP, General Counsel | HQY HealthEquity, Inc. | Sale | 971 | $95.06 | $92.3K Sale | Form 4 ↗ |
| Sep 19, 2025 | Delano Ladd EVP, General Counsel | HQY HealthEquity, Inc. | Sale | 5,000 | $93.91 | $469.6K Sale | Form 4 ↗ |
| Sep 5, 2025 | Evelyn S. Dilsaver Director | HQY HealthEquity, Inc. | Sale | 3,461 | $93.30 | $322.9K Sale | Form 4 ↗ |
| Jul 7, 2025 | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | HQY HealthEquity, Inc. | Sale | 700 | $102.09 | $71.5K Sale | Form 4 ↗ |
| Jul 7, 2025 | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | HQY HealthEquity, Inc. | Sale | 1,094 | $101.50 | $111.0K Sale | Form 4 ↗ |
| Jun 9, 2025 | Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER | HQY HealthEquity, Inc. | Sale | 13,000 | $111.37 | $1.4M Sale | Form 4 ↗ |
| Jun 6, 2025 | Jon Kessler | HQY HealthEquity, Inc. | Sale | 60 | $113.35 | $6,801 Sale | Form 4 ↗ |
| Jun 6, 2025 | Jon Kessler | HQY HealthEquity, Inc. | Sale | 9,628 | $112.61 | $1.1M Sale | Form 4 ↗ |
| Jun 6, 2025 | Jon Kessler | HQY HealthEquity, Inc. | Sale | 16,547 | $111.98 | $1.9M Sale | Form 4 ↗ |
| Jun 6, 2025 | Jon Kessler | HQY HealthEquity, Inc. | Sale | 19,082 | $112.39 | $2.1M Sale | Form 4 ↗ |
| Jun 6, 2025 | Jon Kessler | HQY HealthEquity, Inc. | Sale | 52,450 | $111.83 | $5.9M Sale | Form 4 ↗ |
| Jun 6, 2025 | Jon Kessler | HQY HealthEquity, Inc. | Sale | 15,427 | $112.70 | $1.7M Sale | Form 4 ↗ |
| Jun 6, 2025 | Jon Kessler | HQY HealthEquity, Inc. | Sale | 39,075 | $112.08 | $4.4M Sale | Form 4 ↗ |
| Jun 6, 2025 | Jon Kessler | HQY HealthEquity, Inc. | Sale | 16,854 | $112.38 | $1.9M Sale | Form 4 ↗ |
| Jun 6, 2025 | Jon Kessler | HQY HealthEquity, Inc. | Sale | 62,827 | $111.84 | $7.0M Sale | Form 4 ↗ |
| Jun 6, 2025 | Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER | HQY HealthEquity, Inc. | Sale | 58,000 | $112.56 | $6.5M Sale | Form 4 ↗ |
| Apr 9, 2025 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 400 | $78.81 | $31.5K Sale | Form 4 ↗ |
| Apr 9, 2025 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 3,283 | $78.06 | $256.3K Sale | Form 4 ↗ |
| Apr 9, 2025 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 2,067 | $76.79 | $158.7K Sale | Form 4 ↗ |
| Apr 4, 2025 | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | HQY HealthEquity, Inc. | Sale | 8,881 | $78.26 | $695.0K Sale | Form 4 ↗ |
| Feb 10, 2025 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 1,998 | $111.87 | $223.5K Sale | Form 4 ↗ |
| Feb 10, 2025 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 3,752 | $110.98 | $416.4K Sale | Form 4 ↗ |
| Dec 12, 2024 | Stuart B. Parker Director | HQY HealthEquity, Inc. | Sale | 728 | $97.30 | $70.8K Sale | Form 4 ↗ |
| Dec 12, 2024 | Stuart B. Parker Director | HQY HealthEquity, Inc. | Sale | 24,272 | $96.70 | $2.3M Sale | Form 4 ↗ |
| Dec 12, 2024 | Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER | HQY HealthEquity, Inc. | Sale | 2,869 | $97.12 | $278.6K Sale | Form 4 ↗ |
| Dec 12, 2024 | Debra Charlotte McCowan Director | HQY HealthEquity, Inc. | Sale | 5,000 | $95.56 | $477.8K Sale | Form 4 ↗ |
| Dec 9, 2024 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 2,500 | $101.57 | $253.9K Sale | Form 4 ↗ |
| Dec 9, 2024 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 5,750 | $101.56 | $584.0K Sale | Form 4 ↗ |
| Nov 6, 2024 | Frank Corvino | HQY HealthEquity, Inc. | Sale | 1,039 | $96.10 | $99.8K Sale | Form 4 ↗ |
| Oct 9, 2024 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 1,748 | $83.34 | $145.7K Sale | Form 4 ↗ |
| Oct 9, 2024 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 752 | $82.27 | $61.9K Sale | Form 4 ↗ |
| Oct 9, 2024 | Robert W. Selander Director | HQY HealthEquity, Inc. | Sale | 75 | $83.77 | $6,283 Sale | Form 4 ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:03 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances